cytarabine has been researched along with Cronkhite-Canada Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, M; Fujii, H; Kojima, Y; Koyama, F; Matsumoto, H; Mukogawa, T; Nakajima, Y; Takeuchi, T; Yagi, H | 1 |
1 other study(ies) available for cytarabine and Cronkhite-Canada Syndrome
Article | Year |
---|---|
[Anti-CD20 antibody and combination chemotherapy followed by autologous peripheral blood stem cell transplantation after high-dose chemotherapy induced complete remission in a case of multiple lymphomatous polyposis of the gastrointestinal tract].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Administration Schedule; Etoposide; Humans; Intestinal Neoplasms; Intestinal Polyposis; Lymphoma, Mantle-Cell; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Rituximab | 2003 |